$2.11
-0.09 (-4.09%) today
Moleculin Biotech Inc (MBRX) is down 90.75% over the past year and 13.52% over the past month, trading at $2.11.
Price · today
Key stats
Market cap$11M
Day high$2.18
Day low$2.01
Day open$2.16
Prev close$2.20
ExchangeNASDAQ NMS - GLOBAL MARKET
Performance · all intervals
1D
-4.09%
1W
-14.57%
1M
-13.52%
3M
-51.38%
6M
-80.55%
YTD
-36.25%
1Y
-90.75%
5Y
-99.83%
ALL
-99.99%
Green vs red closes
Last 1D
0up1down
0% green
Last 1W
1up4down
20% green
Last 1M
8up12down
40% green
Last 3M
29up30down
49% green
Last 6M
57up62down
48% green
Year to date
47up42down
53% green
Last 1Y
113up130down
47% green
Last 5Y
525up677down
44% green
Custom Interval
Pick any window — not just the presets above.
days
Related stocks
Compare MBRX with
Latest news on MBRX
Moleculin Biotech Q1 EPS $(3.54) Misses $(1.57) Estimate
Benzinga·20h ago
Moleculin Reports First Quarter 2026 Financial Results and Provides Clinical Update on Pivotal MIRACLE Trial
Finnhub·21h ago
Nano-Cap Moleculin Biotech Approaches Key Leukemia Trial Data Unblinding
Benzinga·2d ago
Moleculin Biotech Inc - to unblind Miracle trial data before June 30, 2026 - SEC filing
Finnhub·2d ago
Moleculin Announces Data From Phase 2B/3 "MIRACLE" Trial Evaluating Annamycin In Combination With Cytarabine
Benzinga·2d ago
Reserved